| Title |
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
|
|---|---|
| Published in |
International Journal of Nanomedicine, February 2012
|
| DOI | 10.2147/ijn.s25182 |
| Pubmed ID | |
| Authors |
Ramya Ranganathan, Shruthilaya Madanmohan, Akila Kesavan, Ganga Baskar, Yoganathan Ramia Krishnamoorthy, Roy Santosham, D Ponraju, Suresh Kumar Rayala, Ganesh Venkatraman |
| Abstract |
The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 241 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| France | 1 | <1% |
| Italy | 1 | <1% |
| China | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 235 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 54 | 22% |
| Student > Master | 47 | 20% |
| Student > Bachelor | 40 | 17% |
| Researcher | 24 | 10% |
| Other | 7 | 3% |
| Other | 27 | 11% |
| Unknown | 42 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 35 | 15% |
| Biochemistry, Genetics and Molecular Biology | 33 | 14% |
| Chemistry | 31 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 30 | 12% |
| Medicine and Dentistry | 24 | 10% |
| Other | 36 | 15% |
| Unknown | 52 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2022.
All research outputs
#5,340,716
of 25,584,565 outputs
Outputs from International Journal of Nanomedicine
#484
of 4,077 outputs
Outputs of similar age
#42,533
of 254,308 outputs
Outputs of similar age from International Journal of Nanomedicine
#10
of 77 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,077 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,308 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.